Mobile

A randomised, parallel-arm, open-label trial comparing degarelix with goserelin plus anti-androgen flare protection (bicalutamide), in terms of volume reduction of the prostate in patients with prosta...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-008604-40

A randomised, parallel-arm, open-label trial comparing degarelix with goserelin plus anti-androgen flare protection (bicalutamide), in terms of volume reduction of the prostate in patients with prostate cancer being candidates for medical castration

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Demonstrate that treatment with degarelix in terms of mean percentage reduction in prostate volume measured with trans-rectal ultrasound (TRUS) is non-inferior to treatment with goserelin plus bicalutamide at 12 weeks compared to baseline

Critère d'inclusion

  • Prostate cancer

Liens